Skip to main content
. 2023 Sep 12;29:e941003-1–e941003-9. doi: 10.12659/MSM.941003

Table 3.

Clinical efficacy evaluation of the 2 groups of patients at the last follow-up.

Grouping Excellent Good Middle Difference Excellent rate
Short-course intensive chemotherapy group (n=53) 62.26% 24.53% 9.43% 3.77% 86.79%
Traditional quadruple chemotherapy group (n=70) 68.57% 15.71% 11.43% 4.29% 84.28%

Comparison of the above 2 groups χ2=0.074, P=0.961.